ABI1 and breast carcinoma: Additionally, dysregulation of ABI1 was confirmed associated with the prognosis of gastric cancer, epithelial ovarian cancer, and breast cancer (Cui et al., 2010; Wang et al., 2011; Zhang et al., 2015).